Aktie A3D4QG AVALON GLOBOCARE CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Avalon GloboCare Corp.

Aktien

A3D4QG

US05344R2031

ALBT

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 28.06.2024 		% 5 Tage % 1. Jan.
0.4703 USD -4.02% Intraday Chart für Avalon GloboCare Corp. -1.82% -2.63%
20.06. Avalon GloboCare Corp. gibt ein Update zur Einführung des KetoAir-Atemtests auf der Konferenz Hack Your Health by KetoCon 2024 CI
31.05. Avalon GloboCare Corp. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference
Avalon GloboCare Corp. Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference
Avalon GloboCare Corp. announced that it has received $2.70275 million in funding from Mast Hill Management, LLC
Avalon GloboCare Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
Avalon GloboCare Corp. Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
North American Morning Briefing : Stock Futures -2-
Avalon GloboCare Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
North American Morning Briefing : Traders Await -2-
North American Morning Briefing : Powell Awaited -2-
Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
Avalon GloboCare Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis
Avalon GloboCare Corp. announced that it has received $0.665 million in funding from Mast Hill Management, LLC, FirstFire Capital Management LLC
Avalon GloboCare Corp. announced that it expects to receive $0.665 million in funding from Mast Hill Management, LLC, FirstFire Capital Management LLC
Apple Approves Use of Avalon GloboCare’s KetoAir Mobile Application
Avalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
Top Midday Gainers
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3D4QG Aktie
  4. Nachrichten Avalon GloboCare Corp.
  5. Andere Sprachen